sacituzumab govitecan
gilead sciences
['sacituzumab', 'breast']
the #oncoalerttoptweet day 2 #asco22 tweet primary results from tropics0 2 phase 3 study of sacituzumab govitecan versus tpc in patients hr+/her2- advanced #breastcancer
best, 
?? Worldwide Network of Oncology Professionals & Patient Advocates with the common goal of ending cancer, we are Oncology360 degrees ?? We are #OncoAlert ??